
OLD Category: immuno-oncology
December 22, 2020 / Cancer Immunol Res
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, Enable
December 21, 2020 / Front Oncol
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
December 20, 2020 / Mol Oncol
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
December 18, 2020 / Cancers (Basel)
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer
December 16, 2020 / Cancer Discov
Direct and Indirect Regulators of Epithelial-Mesenchymal Transition (EMT)-mediated Immunosuppression in Breast Carcinomas
December 15, 2020 / Immunity
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
December 11, 2020 / Brain
Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma
December 10, 2020 / Mol Cancer Ther
Macrophages Mediate the Anti-Tumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors
December 6, 2020 / Oncoimmunology
MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma
December 3, 2020 / Biomedicines